Search clinical trials for: Bortezomib (VELCADE)
Total 951 results
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...TerminatedMyelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Nantes University HospitalTerminatedMultiple MyelomaFrance
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Genzyme, a Sanofi Company; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
European Organisation for Research and Treatment...CompletedMalignant MesotheliomaUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedColorectal CancerCanada
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Singapore General HospitalJanssen-Cilag Ltd.CompletedDiffuse Large B-Cell LymphomaSingapore
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid... and other conditionsUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCompleted
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Cancer Trials IrelandCompleted
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Janssen Research & Development, LLCActive, not recruiting
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, SpainCompleted
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedSystemic Sclerosis | Lung Diseases, Interstitial | SclerodermaUnited States
-
Janssen-Ortho Inc., CanadaTerminated
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Malignant Pleural Effusion | Adenosquamous Cell Lung CancerUnited States
-
Cancer Trials IrelandCompletedMalignant MesotheliomaUnited Kingdom, Ireland, Belgium, Netherlands
-
University of BolognaJanssen-Cilag Ltd.Unknown
-
Assistance Publique - Hôpitaux de ParisCompletedWaldenstrom MacroglobulinemiaFrance
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, United Kingdom, Canada, Israel, France, Austria, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Solid Tumors | Myeloma | Advanced MalignancyUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Millennium Pharmaceuticals, Inc.Withdrawn
-
National Cancer Institute (NCI)TerminatedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Scios, Inc.Completed
-
National Cancer Institute (NCI)CompletedSquamous Cell CarcinomaUnited States
-
Scios, Inc.Completed
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
University of FloridaNovartis PharmaceuticalsWithdrawn